Pan-Cancer Analyses Refine the Single-Cell Portrait of Tumor-Infiltrating Dendritic Cells.

Area of Science:

• Immunology
• Cancer Biology
• Single-cell Genomics

Background:

• Dendritic cells (DCs) are crucial for anti-tumor immunity, but current DC-based therapies have limited clinical success.
• Understanding DC heterogeneity within the tumor microenvironment (TME) is key to improving immunotherapies.

Purpose of the Study:

• To create a comprehensive human DC atlas by integrating single-cell RNA sequencing data from diverse cancer types.
• To identify and characterize rare DC subsets within tumors and explore their functional significance.
• To develop computational tools for DC analysis and identify targets for enhanced DC vaccination.

Main Methods:

• Integrated single-cell RNA sequencing data from over 2,500 tumor samples across 33 cancer types.
• Performed computational analyses to identify DC subsets, their origins, and transcriptomic characteristics.
• Developed a machine learning model for DC annotation and target identification.

Main Results:

• Established a comprehensive blueprint of human tumor-infiltrating dendritic cells.
• Identified rare DC subsets, including AXL+SIGLEC6+ (AS) DCs and Langerhans cell (LC)-like DCs, with distinct transcriptomic profiles.
• Demonstrated that LC-like DCs can be a cellular origin for LAMP3+ DCs, linking cellular origin to functional potential.

Conclusions:

• The DC atlas provides a detailed view of tumor-infiltrating DC complexity.
• Insights into DC heterogeneity and origins can guide the development of novel DC-based anti-tumor immunotherapies.
• The developed machine learning model and identified targets offer potential for enhancing anti-tumor DC vaccination strategies.